Citation Impact
Citing Papers
Biomedically-relevant metal organic framework-hydrogel composites
2023 StandoutNobel
Pulmonary Delivery of Therapeutic and Diagnostic Gases
2018
Monitoring cyclodextrin–polyviologen pseudopolyrotaxanes with the Bradford assay
2005 StandoutNobel
Cyclodextrins as pharmaceutical solubilizers
2007 Standout
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial
2017
Spinal Nociception Induced by Intramuscular Injection of Oxytetracycline Preparations in Rats and Pigs
2006
Piroxicam-??-Cyclodextrin
1994
Bisphenol A and human health: A review of the literature
2013 Standout
Molecular effects of genistein on estrogen receptor mediated pathways
1996 Standout
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
2005 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Novel Oral Drug Formulations
1994
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Placebo-controlled comparison of piroxicam-?-cyclodextrin, piroxicam, and indomethacin on gastric potential difference and mucosal injury in humans
1992
Improving drug solubility for oral delivery using solid dispersions
2000 Standout
Dietary Intake and Bioavailability of Polyphenols
2000 Standout
Microemulsion-based media as novel drug delivery systems
2000 Standout
Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications
2001
Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone
1996
Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer
2004 Standout
Design and development of polymers for gene delivery
2005 Standout
Legumes and soybeans: overview of their nutritional profiles and health effects
1999 Standout
Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver
1998
Asthma
2017 Standout
Adverse Drug Events Related to Dosage Forms and Delivery Systems
1996
Nanoporous Carbohydrate Metal–Organic Frameworks
2011 StandoutNobel
Influence of physicochemical properties on dissolution of drugs in the gastrointestinal tract1PII of original article: S0169-409X(96)00487-5. The article was originally published in Advanced Drug Delivery Reviews 25 (1997) 3–14.1
2001
Bioactive compounds in foods: their role in the prevention of cardiovascular disease and cancer
2002 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Flavonoids: Old and new aspects of a class of natural therapeutic drugs
1999 Standout
The biochemistry and medical significance of the flavonoids
2002 Standout
Polyphenols: food sources and bioavailability
2004 Standout
Pharmaceutical Applications of Cyclodextrins. 2. In Vivo Drug Delivery
1996
Oral anti-inflammatory and anti-ulcerogenic activities of a hydroalcoholic extract and partitioned fractions of Turnera ulmifolia (Turneraceae)
1998
Designing hydrogels for controlled drug delivery
2016 Standout
Inclusion complex of piroxicam with β-cyclodextrin and incorporation in hexadecyltrimethylammonium bromide based microemulsion
1999
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Pharmacokinetics of Oxicam Nonsteroidal Anti-Inflammatory Agents
1994
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Effect of passive and iontophoretic skin pretreatments with terpenes on the in vitro skin transport of piroxicam
2001
Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial
2013
Daidzein Is a More Bioavailable Soymilk Isoflavone than Is Genistein in Adult Women
1994
Thymol, a constituent of thyme essential oil, is a positive allosteric modulator of human GABAA receptors and a homo‐oligomeric GABA receptor from Drosophila melanogaster
2003 Standout
Suppressive Effect of Curcumin on Trichloroethylene-induced Oxidative Stress.
2000
Cyclodextrins for drug delivery
2010
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance
2009 Standout
Bioavailability of Soybean Isoflavones Depends upon Gut Microflora in Women
1995
Supramolecular biomaterials
2015 Standout
Preparation of inclusion complex of piroxicam with cyclodextrin by using supercritical carbon dioxide
2008
Cyclodextrins in drug delivery
2005
Classification of Drug Permeability with a Caco-2 Cell Monolayer Assay
2007
Isoflavones, lignans and stilbenes - origins, metabolism and potential importance to human health
2000
A study on the differentiation between amorphous piroxicam:β-cyclodextrin complex and a mixture of the two amorphous components
1996
Properties of Resveratrol:In VitroandIn VivoStudies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans
2015 Standout
DIETARY FLAVONOIDS : Bioavailability, Metabolic Effects, and Safety
2002 Standout
Cyclodextrin Drug Carrier Systems
1998 Standout
Review: A History of Cyclodextrins
2014 Standout
The Reciprocal Interactions between Polyphenols and Gut Microbiota and Effects on Bioaccessibility
2016 Standout
Phenolic compounds and related enzymes as determinants of quality in fruits and vegetables
2001 Standout
Administration of substances to laboratory animals: routes of administration and factors to consider.
2011 Standout
Clinical Pharmacology of Piroxicam-??-Cyclodextrin
2000
Formation of ring-in-ring complexes between crown ethers and rigid TVBox8+
2014 StandoutNobel
Plant Foods and Herbal Sources of Resveratrol
2002 Standout
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
2012
Cyclodextrins and their uses: a review
2003 Standout
The Essential Medicinal Chemistry of Curcumin
2017 Standout
Works of Daniela Acerbi being referenced
Lung Deposition of BDP/Formoterol HFA pMDI in Healthy Volunteers, Asthmatic, and COPD Patients
2010
Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo‐controlled, crossover study
2004
Induction of peroxisomal β-oxidation and P-450 4A-dependent activities by pivalic and trichloroacetic acid in rat liver and kidney
1996
Oral bioavailability of CHF1194, an inclusion complex of piroxicam and ?-cyclodextrin, in healthy subjects under single dose and steady-state conditions
1995
Systemic Exposure and Implications for Lung Deposition with an Extra-Fine Hydrofluoroalkane Beclometasone Dipropionate/Formoterol Fixed Combination
2009
Validation of a Caco-2 cell monolayer culture for drug transport studies.
1998
Steady-state pharmacokinetics of ipriflavone and its metabolites in patients with renal failure.
1991
Plasma and synovial fluid concentrations of piroxicam during prolonged treatment with piroxicam pivalic ester.
1987
Supermolecular inclusion of piroxicam with beta-cyclodextrin: pharmacokinetic properties in man.
1993
Pharmacokinetic Profile of Piroxicam-β-Cyclodextrin
1990
Supermolecular inclusion of piroxicam with beta-cyclodextrin: a review of its pharmacological properties in laboratory animals.
1993
Lung Deposition of Formoterol HFA (Atimos®/Forair®) in Healthy Volunteers, Asthmatic and COPD Patients
2007
Pharmacokinetic study on piroxicam at the steady-state in elderly subjects and younger adults after administration of piroxicam beta-cyclodextrin.
1988
Biopharmaceutical Optimisation of β-Cyclodextrin Inclusion Compounds
1990
Some pharmacokinetic properties and bioavailability by oral and rectal route of piroxicam in rodents and in man.
1981
A tolerability andpharmacokinetic study of a newinjectable formulation of disodium clodronate in healthyfemale volunteers
2004
Antiinflammatory activity and bioavailability of percutaneous piroxicam.
1982
Rapid Oral Absorption Profile of Piroxicam from its β-Cyclodextrin Complex
1990